Association for Accessible Medicine
The Association for Accessible Medicines (AAM), headquartered in the United States, is a leading advocate for the generic and biosimilar medicines industry. Founded in 2016, AAM has quickly established itself as a pivotal player in promoting access to affordable medications across the nation. The organisation focuses on key areas such as policy advocacy, education, and research, aiming to enhance the understanding and availability of accessible medicines. AAM's core services include providing resources and support for stakeholders in the pharmaceutical sector, while championing the benefits of generic and biosimilar products. With a commitment to improving patient access and healthcare affordability, AAM has achieved significant milestones, positioning itself as a trusted voice in the industry. Its efforts have contributed to a more competitive marketplace, ultimately benefiting consumers and healthcare providers alike.
DitchCarbon Score
How does Association for Accessible Medicine's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Association for Accessible Medicine's score of 3 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Association for Accessible Medicine's reported carbon emissions
The Association for Accessible Medicine, headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the organisation may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. As the industry increasingly prioritises sustainability, it is essential for organisations like the Association for Accessible Medicine to establish clear emissions reduction strategies and targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Association for Accessible Medicine is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
